Popular Diabetes Medications May Protect Against Alzheimer’s Disease, UF Researchers Find
UF researchers have found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer’s disease and related dementias in patients with Type 2 diabetes.
Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel To Monitor Treatment Journey for Patients With Traumatic Brain Injury and Alzheimer’s
UF Innovate's funding institution Gryphon Bio, Inc. is pursuing observational clinical studies with U.S. and international partners to validate a novel blood biomarker panel for early detection and monitoring of TBI and Alzheimer’s disease.
